Advarra

02/01/2023

Join us in celebrating the trailblazers of clinical research this 🎉 Advarra is excited to shine a light on the impactful contributions of key historical figures who have shaped our field. Today we are starting off with a tribute to Dr. Rebecca Lee Crumpler. Stay tuned as we pay tribute to these pioneers.

01/24/2023

We're dedicated to serving the clinical research community at Advarra, and that means staying on top of the latest trends. Our new eBook, "2023 Trends Impacting Clinical Research," is a valuable resource that can help you stay informed and adapt to the changes in the industry.

https://bit.ly/3RbN09J

01/17/2023

Join us 1/26 for a webinar on the latest trends in regulatory and development challenges for rare/orphan diseases. Learn successful strategies for a proactive approach to gaining a rare/orphan disease designation and identify critical issues and steps to resolve them to achieve regulatory and development milestones. CE credits available. Register now!

https://info.advarra.com/trending-now-wbnr.html?utm_medium=social-media&utm_source=facebook&utm_campaign=trending-now-wbnr&utm_content=trending-now-wbnr

Explore the latest trends in regulatory and development challenges for rare/orphan diseases.

01/13/2023

If you’re not already using a single IRB (sIRB) for cooperative and multisite clinical trials, you probably will be soon. Relying on an sIRB can be challenging for institutions used to doing everything locally. Even those more familiar with sIRB reliance may still find it’s not as efficient or straightforward as promised. https://bit.ly/3CHFjlJ

Find out how other institutions have used sIRB requirements as an opportunity to elevate their research programs.

11/10/2022

An investigator-initiated trial (IIT) occurs when an investigator creates the idea for a study, develops the protocol, and serves as the sponsor and investigator for the trial. While this isn’t uncommon, careful planning is required in order for these trials to be successfully compliant.

Download our latest eBook: https://bit.ly/3EoEVdc

07/12/2022

This case study outlines how a biopharmaceutical company partnered with Advarra to execute a phased approach to identify opportunities for improvement, analyze their current pharmacovigilance system state, and implement R&D industry best practices for regulatory compliance.

Learn how an organization achieved organization-wide compliance and managed its post-authorization safety studies

07/11/2022

Is your IRB prepared to review protocols involving mHealth and virtual trial apps?

What questions should you ask the sponsor or researcher about these technologies?

How can researchers at your institution better plan their protocols and documentation to aide IRB review?

Explore the current regulatory landscape governing mHealth and virtual trial applications.

07/06/2022

Understanding the factors that influence the decision to participate in a study helps research professionals diagnose enrollment problems.

Understanding the factors that influence the decision to participate in a study helps research professionals diagnose enrollment problems.

07/05/2022

Research into participant experiences has consistently shown their desire to learn the results of research to which they’ve contributed. https://bit.ly/3NM9XwK

Research into participant experiences has consistently shown their desire to learn the results of research to which they’ve contributed.

07/02/2022

Curious about how AI is used in clinical research? Want to learn more about discriminatory AI?

Check out the latest episode of "Advarra in Conversations With…" to listen to Advarra IRB Chairperson Luke Gelinas and AI Ethics Advisor Reid Blackman Ph.D. discuss AI ethics and implications for clinical research. Don't miss out on this exciting and informative conversation!

The future of healthcare innovation hinges on research and clinical trials. The Advarra In Conversations With Podcast sits down with leading experts to dig into pressing issues and explore cornerstone solutions.

06/24/2022

Regulatory agency guidance in the U.S. and EU strongly recommends keeping DSMBs completely independent from parties sponsoring, organizing, or conducting the clinical trial. Get the unblinded truth on what a DSMB does and how to set one up in this free white paper.

This white paper describes how to set up a data safety monitoring board and it's role in clinical research.

06/23/2022

Institutional sites are critical to successful clinical research and the advancement of healthcare. That’s why at Advarra, everything we do is driven by site centricity. In this blog, learn how Advarra plays a role in the movement toward site centricity.

Find out how we keep site centricity at the forefront through our technology, services, and extraordinary team members.